SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

BlackRock Health Sciences Trust II BMEZ NYSE

NYSE • Financial Services • Asset Management • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

BlackRock Health Sciences Trust II (BMEZ) is a Asset Management company in the Financial Services sector, currently trading at $14.77. It has a SharesGrow Score of 85/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $24M, +25.1%/yr average growth. Net income is $23M, growing at +16%/yr. Net profit margin is 97.4% (strong). Gross margin is 100% (+89.3 pp trend).

Balance sheet: total debt is $278,058 against $769M equity (Debt-to-Equity (D/E) ratio 0, conservative). Debt-to-assets is 0%. Total assets: $775M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 62/100 (Partial), Future ?/100 (Fail), Income 100/100 (Pass).

BMEZ SharesGrow Score Overview

88/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 75/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 62/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BMEZ

BMEZ trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

BMEZ: +25.1%/yr revenue is, +16%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

BMEZ: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet BMEZ: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

BMEZ: Gross margin is 100% (+89.3 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 62/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

BMEZ: Net profit margin is 97.4%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range12.58-15.8

Volume244.45K

Avg Volume (30D)268.06K

Market Cap$1.5B

Beta (1Y)0.92

Dividend Yield$1.6693

Share Statistics

EPS (TTM)1.77

Shares Outstanding$13.26M

IPO Date2020-01-29

CEOXiang Liu

Financial Highlights & Ratios

Revenue (TTM)$24.07M

Gross Profit$24.07M

EBITDA$23.5M

Net Income$23.45M

Operating Income$927.18K

Total Cash$26.56M

Total Debt$278.06K

Net Debt$-71.34K

Total Assets$774.59M

Price / Earnings (P/E)8.3

Price / Sales (P/S)62.13

Analyst Forecast

Company Info

CountryUS

ExchangeNYSE

CurrencyUSD

ISINUS09260E1055

Price Chart

BMEZ

BlackRock Health Sciences Trust II · NYSE

Financial Services • Asset Management

12.58 52WK RANGE 15.80

People Also View

Blackrock Innovation & Growth Trust

BlackRock Science and Technology Trust II

BlackRock Capital Allocation Trust

BlackRock ESG Capital Allocation Trust

BlackRock Science and Technology Trust

Eaton Vance Enhanced Equity Income Fund II

Neuberger Berman Next Generation Connectivity Fund Inc.

Blackrock Resources & Commodities Strategy Trust

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message